{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:18:49Z","timestamp":1781853529281,"version":"3.54.5"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.euroneuro.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T05:20:21Z","timestamp":1655356821000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-4203","authenticated-orcid":false,"given":"Xenia","family":"Gonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-6722","authenticated-orcid":false,"given":"Berta","family":"Erdelyi-Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Priyanka","family":"Elek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-7983","authenticated-orcid":false,"given":"Samata R.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Tarazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.05.010_bib0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010818-021701","article-title":"The neurobiology and pharmacotherapy of posttraumatic stress disorder","volume":"59","author":"Abdallah","year":"2019","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2017.04.046","article-title":"Neurobiology of posttraumatic stress disorder (PTSD): a path from novel pathophysiology to innovative therapeutics","volume":"649","author":"Abdallah","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0003","doi-asserted-by":"crossref","first-page":"14120","DOI":"10.1073\/pnas.0903183106","article-title":"Human vulnerability to stress depends on amygdala's predisposition and hippocampal plasticity","volume":"106","author":"Admon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainresbull.2019.09.011","article-title":"Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial","volume":"153","author":"Ahmadizadeh","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11920-017-0840-4","article-title":"A Network-Based Neurobiological Model of PTSD: evidence From Structural and Functional Neuroimaging Studies","volume":"19","author":"Akiki","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuroimage.2018.05.005","article-title":"Default mode network abnormalities in posttraumatic stress disorder: a novel network-restricted topology approach","volume":"176","author":"Akiki","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0007","article-title":"Characterization of comorbid posttraumatic stress disorder and major depressive disorder using ketamine as an experimental medicine probe \u2020","volume":"6","author":"Albott","year":"2021","journal-title":"Journal of psychiatry and brain science"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0008","first-page":"32","article-title":"Pharmacotherapy for post-traumatic stress disorder in combat veterans: focus on antidepressants and atypical antipsychotic agents","volume":"37","author":"Alexander","year":"2012","journal-title":"P T"},{"issue":"7","key":"10.1016\/j.euroneuro.2022.05.010_bib0009","article-title":"Pharmacological interventions for preventing post-traumatic stress disorder (PTSD)","author":"Amos","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0010","unstructured":"Aptinyx Press Release. Aptinyx Reports Positive, Statistically Significant, Top-line Data from Phase 2 Study of NYX-783 in Patients with Post-Traumatic Stress Disorder. October 19, 2020."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0012","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12888-019-2375-1","article-title":"Longitudinal trajectories of comorbid PTSD and depression symptoms among U.S. service members and veterans","volume":"13","author":"Armenta","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2015.04.006","article-title":"Prevention of posttraumatic stress disorder with propranolol: a meta-analytic review","volume":"79","author":"Argolo","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pscychresns.2016.12.004","article-title":"Evidence for the changes of pituitary volumes in patients with post-traumatic stress disorder","volume":"260","author":"Atmaca","year":"2017","journal-title":"Psychiatry Res Neuroimag."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.9740\/mhc.2017.03.088","article-title":"D-cycloserine in the treatment of posttraumatic stress disorder","volume":"7","author":"Baker","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09540261.2021.1919062","article-title":"Psilocybin and MDMA for the treatment of trauma-related psychopathology","volume":"33","author":"Bird","year":"2021","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0017","doi-asserted-by":"crossref","first-page":"h6161","DOI":"10.1136\/bmj.h6161","article-title":"Post-traumatic stress disorder","volume":"351","author":"Bisson","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.euroneuro.2022.05.010_bib0018","first-page":"22","article-title":"Comorbidity of psychiatric disorders and posttraumatic stress disorder","volume":"61","author":"Brady","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0019","first-page":"6","article-title":"Functional neuroanatomical correlates of traumatic stress revisited 7 years later, this time with data","volume":"37","author":"Bremner","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2006.8.4\/jbremner","article-title":"Traumatic stress: effects on the brain","volume":"8","author":"Bremner","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0021","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/ajp.152.7.973","article-title":"MRI-Based measurement of hippocampal volume in patients with combat-related posttraumatic-stress-disorder","volume":"152","author":"Bremner","year":"1995","journal-title":"Am J Psychiat"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2007.05.006","article-title":"Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder","volume":"42","author":"Brunet","year":"2008","journal-title":"J Psychiat Res"},{"issue":"5","key":"10.1016\/j.euroneuro.2022.05.010_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1176\/appi.ajp.2017.17050481","article-title":"Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial","volume":"175","author":"Brunet","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.05.010_bib0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/wps.20656","article-title":"Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges","volume":"18","author":"Bryant","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0026","first-page":"274","article-title":"Glutamate and post-traumatic stress disorder: towards a psychobiology of dissociation","volume":"4","author":"Chambers","year":"1999","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0027","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1037\/0022-006X.70.5.1067","article-title":"Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse","volume":"70","author":"Cloitre","year":"2002","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.05.010_bib0028","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1176\/appi.ajp.161.3.515","article-title":"Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study","volume":"161","author":"Cohen","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0029","series-title":"COMPASS Pathways Announces Positive Topline Results from Groundbreaking Phase IIb Trial of investigational COMP360 psilocybin therapy for treatment-resistant depression","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0030","series-title":"COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1503\/jpn.100050","article-title":"Default mode alterations in posttraumatic stress disorder related to early-life trauma: a developmental perspective","volume":"36","author":"Daniels","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0032","first-page":"8","article-title":"A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans","volume":"41","author":"Davis","year":"2008","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.05.010_bib0033","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2019.07.009","article-title":"Translating molecular and neuroendocrine findings in PTSD and resilience to novel therapies","volume":"86","author":"DePierro","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2022.05.010_bib0034","article-title":"Combining Xenon inhalation with trauma memory reactivation to reduce symptoms of posttraumatic stress disorder: case report, justification of approach, and review of the literature","volume":"21","author":"Dobrovolsky","year":"2019","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biopsych.2017.06.024","article-title":"Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with Posttraumatic Stress Disorder","volume":"82","author":"Dunlop","year":"2017","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1196\/annals.1296.003","article-title":"Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress","volume":"1018","author":"Dunn","year":"2004","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0037","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1524838018813198","article-title":"Risk for mental disorders associated with sexual assault: a meta-analysis","volume":"21","author":"Dworkin","year":"2020","journal-title":"Trauma Violence Abuse"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0038","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pbb.2013.12.001","article-title":"Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides","volume":"117","author":"Enman","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0039","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1467-9280.2007.01860.x","article-title":"Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder","volume":"18","author":"Felmingham","year":"2007","journal-title":"Psychol Science"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nlm.2013.09.017","article-title":"Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies","volume":"112","author":"Finsterwald","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0043","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1037\/0022-006X.67.2.194","article-title":"A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims","volume":"67","author":"Foa","year":"1999","journal-title":"J Consult Clin Psych"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0044","series-title":"Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences: Therapist Guide","author":"Foa","year":"2007"},{"issue":"12","key":"10.1016\/j.euroneuro.2022.05.010_bib0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/appi.ajp.2017.16091073","article-title":"Selective effects of psychotherapy on frontopolar cortical function in PTSD","volume":"174","author":"Fonzo","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0046","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nn958","article-title":"Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma","volume":"5","author":"Gilbertson","year":"2002","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0047","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jnr.25017","article-title":"Hallucinogenic drugs and their potential for treating fear-related disorders: through the lens of fear extinction","volume":"100","author":"Glavonic","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0048","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnbeh.2018.00127","article-title":"A comprehensive overview on stress neurobiology: basic concepts and clinical implications","volume":"12","author":"Godoy","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0049","first-page":"1","article-title":"Novel antidepressant drugs: beyond monoamine targets","volume":"30","author":"Gonda","year":"2021","journal-title":"CNS Spectr. Sep."},{"issue":"4","key":"10.1016\/j.euroneuro.2022.05.010_bib0050","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s13311-020-00871-0","article-title":"Treating post-traumatic stress disorder with neuromodulation therapies: transcranial magnetic stimulation, transcranial direct current Stimulation, and deep brain stimulation","volume":"17","author":"Gouveia","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0051","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/brainsci9020045","article-title":"Neuromodulation strategies in post-traumatic stress disorder: from preclinical models to clinical applications","volume":"9","author":"Gouveia","year":"2019","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.euroneuro.2022.05.010_bib0052","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: a Systematic Review and Meta-Analysis","volume":"21","author":"Guina","year":"2022","journal-title":"J. Psychiatr. Pract."},{"issue":"Pt B","key":"10.1016\/j.euroneuro.2022.05.010_bib0053","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.expneurol.2016.05.014","article-title":"Noradrenergic dysregulation in the pathophysiology of PTSD","volume":"284","author":"Hendrickson","year":"2016","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.05.010_bib0054","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00005373-200211000-00012","article-title":"Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: women are at higher risk of adverse outcomes than men","volume":"53","author":"Holbrook","year":"2002","journal-title":"J. Trauma"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0055","article-title":"Pharmacological-assisted Psychotherapy for Post-Traumatic Stress Disorder: a systematic review and meta-analysis","volume":"12","author":"Hoskins","year":"2021","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0056","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.2015.261","article-title":"Prevention of trauma and stressor-related disorders: a review","volume":"41","author":"Howlett","year":"2016","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0057","article-title":"Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature","volume":"14","author":"Hudson","year":"2012","journal-title":"Prim Care Companion CNS Disord."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0058","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2022.2063274","article-title":"Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?","author":"Husain","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0059","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-1781(95)02673-K","article-title":"Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety - Elements of face and predictive-validity","volume":"57","author":"Jenck","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03040918","article-title":"Increase of serum triiodothyronine concentration in soldiers with combat-related chronic post-traumatic stress disorder with or without alcohol dependence","volume":"116","author":"Karlovic","year":"2004","journal-title":"Wien. Klin. Wochenschr."},{"issue":"5","key":"10.1016\/j.euroneuro.2022.05.010_bib0061","first-page":"4","article-title":"Posttraumatic stress disorder: the burden to the individual and to society","volume":"61","author":"Kessler","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0062","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.7205\/MILMED-D-13-00298","article-title":"Randomized controlled trial of accelerated resolution therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD)","volume":"178","author":"Kip","year":"2013","journal-title":"Mil. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0063","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jts.20685","article-title":"A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial","volume":"24","author":"Kent","year":"2011","journal-title":"J. Trauma Stress"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0064","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(07)67025-3","article-title":"Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder","volume":"167","author":"de Kloet","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1037\/0021-843X.117.2.460","article-title":"The developmental mental-disorder histories of adults with posttraumatic stress disorder: a prospective longitudinal birth cohort study","volume":"117","author":"Koenen","year":"2008","journal-title":"J. Abnorm. Psychol."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0066","doi-asserted-by":"crossref","DOI":"10.1080\/20008198.2019.1654782","article-title":"Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis","volume":"10","author":"Kothgassner","year":"2019","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0067","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jchemneu.2013.05.003","article-title":"CRH: the link between hormonal-, metabolic- and behavioral responses to stress","volume":"54","author":"Kov\u00e1cs","year":"2013","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0068","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2019.01.004","article-title":"One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial","volume":"273","author":"Kozel","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0069","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0071","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.03.044","article-title":"Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience","volume":"1293","author":"Krystal","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0072","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-022-01498-7","article-title":"Positive modulation of N-methyl-D-aspartate receptors in the mPFC reduces the spontaneous recovery of fear","author":"Lee","year":"2022","journal-title":"Mol Psychiatry in press"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0073","doi-asserted-by":"crossref","DOI":"10.1080\/20008198.2018.1550344","article-title":"The effectiveness of narrative exposure therapy: a review, meta-analysis and meta-regression analysis","volume":"10","author":"Lely","year":"2019","journal-title":"Eur. J.. Psychotraumatol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0074","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2215-0366(19)30031-8","article-title":"The epidemiology of trauma and post-traumatic stress disorder in a representative cohort of young people in England and Wales","volume":"6","author":"Lewis","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fpsyg.2020.00080","article-title":"Effects of electroconvulsive therapy on depression and its potential mechanism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0076","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.biopsych.2017.09.006","article-title":"Smaller hippocampal volume in Posttraumatic Stress Disorder: a Multisite ENIGMA-PGC Study: subcortical volumetry results from Posttraumatic Stress Disorder Consortia","volume":"83","author":"Logue","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0077","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2019.02.001","article-title":"Recent advances in the neurobiology of posttraumatic stress disorder: a review of possible mechanisms underlying an effective pharmacotherapy","volume":"142","author":"Malikowska-Racia","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0078","doi-asserted-by":"crossref","DOI":"10.1080\/20008198.2021.1929025","article-title":"Does trauma-focused psychotherapy change the brain? A systematic review of neural correlates of therapeutic gains in PTSD","volume":"12","author":"Manthey","year":"2021","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0079","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.janxdis.2018.10.006","article-title":"When translational neuroscience fails in the clinic: dexamethasone prior to virtual reality exposure therapy increases drop-out rates","volume":"61","author":"Maples-Keller","year":"2019","journal-title":"J. Anxiety Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4088\/JCP.15r10334","article-title":"A meta-analysis of D-cycloserine in exposure-based treatment: moderators of treatment efficacy, response, and diagnostic remission","volume":"78","author":"McGuire","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0081","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.psych.54.101601.145112","article-title":"Progress and controversy in the study of posttraumatic stress disorder","volume":"54","author":"McNally","year":"2003","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0082","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archgenpsychiatry.2011.50","article-title":"Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies","volume":"68","author":"Mehta","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2022.05.010_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106189","article-title":"Xenon impairs reconsolidation of fear memories in a rat model of post-traumatic stress disorder (PTSD)","volume":"9","author":"Meloni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0084","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tics.2011.08.003","article-title":"Large-scale brain networks and psychopathology: a unifying triple network model","volume":"15","author":"Menon","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2022.05.010_bib0086","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0087","first-page":"S71","article-title":"Fear learning circuitry is biased toward generalization of fear associations in Posttraumatic Stress Disorder","volume":"40","author":"Morey","year":"2015","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0088","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820930321","article-title":"The role of the locus coeruleus in the generation of pathological anxiety","volume":"4","author":"Morris","year":"2020","journal-title":"Brain Neurosci. Adv."},{"issue":"Pt A","key":"10.1016\/j.euroneuro.2022.05.010_bib0089","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neubiorev.2016.10.012","article-title":"The periaqueductal gray and primal emotional processing critical to influence complex defensive responses, fear learning and reward seeking","volume":"76","author":"Motta","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0090","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1176\/ajp.2006.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment","volume":"163","author":"Neylan","year":"2006","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0091","series-title":"Effects of a Psychedelic 5-HT2A Receptor Agonist on Anxiety-Related Behavior and Fear Processing in Mice","author":"P\u0119dzich","year":"2022"},{"issue":"7","key":"10.1016\/j.euroneuro.2022.05.010_bib0092","doi-asserted-by":"crossref","first-page":"e30334","DOI":"10.2196\/30334","article-title":"Combining ketamine and internet-based cognitive behavioral therapy for the treatment of posttraumatic stress disorder: protocol for a randomized controlled trial","volume":"10","author":"Philipp-Muller","year":"2021","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0093","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-3223(01)01279-3","article-title":"Pilot study of secondary prevention of posttraumatic stress disorder with propranolol","volume":"51","author":"Pitman","year":"2002","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0094","first-page":"47","article-title":"Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging","volume":"62","author":"Pitman","year":"2001","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0079-6123(07)67017-4","article-title":"Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD","volume":"167","author":"de Quervain","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0096","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn.2016.155","article-title":"Stress, glucocorticoids and memory: implications for treating fear-related disorders","volume":"18","author":"de Quervain","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0097","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1507598","article-title":"Trial of prazosin for Post-Traumatic Stress Disorder in military veterans","volume":"378","author":"Raskind","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0098","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","article-title":"Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - Past, present, and future","volume":"60","author":"Rauch","year":"2006","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0099","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/cyber.2009.0239","article-title":"Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD","volume":"13","author":"Ready","year":"2010","journal-title":"Cyberpsychol. Behav. Soc. Netw."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0022-006X.60.5.748","article-title":"Cognitive processing therapy for sexual assault victims","volume":"60","author":"Resick","year":"1992","journal-title":"J. Consult. Clin. Psych"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0101","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1176\/ajp.152.11.1675","article-title":"Effect of previous trauma on acute plasma-cortisol level following rape","volume":"152","author":"Resnick","year":"1995","journal-title":"Am. J. Psychia.t"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0102","first-page":"61","article-title":"Compelling evidence that exposure therapy for PTSD normalizes brain function","volume":"199","author":"Roy","year":"2014","journal-title":"Stud. Health Technol. Inform."},{"issue":"3","key":"10.1016\/j.euroneuro.2022.05.010_bib0103","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jts.21814","article-title":"The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis","volume":"26","author":"Rytwinski","year":"2013","journal-title":"J. Trauma Stress"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.05.010_bib0104","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13554794.2014.890727","article-title":"Working memory training with tDCS improves behavioral and neurophysiological symptoms in pilot group with post-traumatic stress disorder (PTSD) and with poor working memory","volume":"21","author":"Saunders","year":"2015","journal-title":"Neurocase"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1521\/psyc.2008.71.2.134","article-title":"Nonresponse and dropout rates in outcome studies on PTSD: review and methodological considerations","volume":"71","author":"Schottenbauer","year":"2008","journal-title":"Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0106","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy","volume":"10","author":"Sessa","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"25","key":"10.1016\/j.euroneuro.2022.05.010_bib0107","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMra1612499","article-title":"Post-traumatic stress disorder","volume":"376","author":"Shalev","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.31887\/DCNS.2011.13.2\/jsherin","article-title":"Post-traumatic stress disorder: the neurobiological impact of psychological trauma","volume":"13","author":"Sherin","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0109","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S2215-0366(14)00121-7","article-title":"Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis","volume":"2","author":"Sijbrandij","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2022.05.010_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000348867","article-title":"Neurosubstrates of remission following prolonged exposure therapy in veterans with posttraumatic stress disorder","volume":"82","author":"Simmons","year":"2013","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0111","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/PSY.0b013e318273bf33","article-title":"Neural dysregulation in Posttraumatic Stress Disorder: evidence for disrupted equilibrium between salience and default mode brain networks","volume":"74","author":"Sripada","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0112","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for military-related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0113","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.beth.2011.03.003","article-title":"An integrated approach to delivering exposure-based treatment for symptoms of PTSD and depression in OIF\/OEF veterans: preliminary findings","volume":"43","author":"Strachan","year":"2012","journal-title":"Behav Ther"},{"issue":"3","key":"10.1016\/j.euroneuro.2022.05.010_bib0114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.brs.2021.03.015","article-title":"Electroconvulsive therapy with a memory reactivation intervention for post-traumatic stress disorder: a randomized controlled trial","volume":"14","author":"Tang","year":"2021","journal-title":"Brain Stimul"},{"issue":"6","key":"10.1016\/j.euroneuro.2022.05.010_bib0115","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s11606-021-06731-7","article-title":"Post-traumatic stress disorder among COVID-19 survivors at 3-month follow-up after Hospital discharge","volume":"36","author":"Tarsitani","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0116","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jnr.24447","article-title":"The effects of trauma on brain and body: a unifying role for the midbrain periaqueductal gray","volume":"97","author":"Terpou","year":"2019","journal-title":"J. Neurosci. Res."},{"issue":"11","key":"10.1016\/j.euroneuro.2022.05.010_bib0117","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1017\/S0033291712000499","article-title":"Treatment effects on insular and anterior cingulate cortex activation during classic and emotional Stroop interference in child abuse-related complex post-traumatic stress disorder","volume":"42","author":"Thomaes","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0118","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2019.09.013","article-title":"Risk factors for posttraumatic stress disorder: an umbrella review of systematic reviews and meta-analysis","volume":"107","author":"Tortella-Feliu","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psychres.2016.05.013","article-title":"Is plasma GABA level a biomarker of Post-Traumatic Stress Disorder (PTSD) severity? A preliminary study","volume":"241","author":"Trousselard","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2003.08.009","article-title":"Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder","volume":"55","author":"Vaiva","year":"2004","journal-title":"Biol. Psychiat"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2000.2.1\/bvdkolk","article-title":"Posttraumatic stress disorder and the nature of trauma","volume":"2","author":"Van der Kolk","year":"2000","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brs.2018.09.011","article-title":"Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results","volume":"12","author":"van 't Wout-Frank","year":"2019","journal-title":"Brain Stimul"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0123","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/da.10017","article-title":"Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder","volume":"16","author":"Vermetten","year":"2002","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0124","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41380-020-00967-1","article-title":"Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2022.05.010_bib0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.yct.0000264369.38033.34","article-title":"Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder","volume":"23","author":"Watts","year":"2007","journal-title":"J. ECT"},{"issue":"1","key":"10.1016\/j.euroneuro.2022.05.010_bib0126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brs.2011.02.002","article-title":"A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder","volume":"5","author":"Watts","year":"2012","journal-title":"Brain Stimul."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0127","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jagp.2020.06.022","article-title":"A review of PTSD augmentation strategies for older adults and case of rTMS-augmented prolonged exposure","volume":"28","author":"Yasinski","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1364.012","article-title":"Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications","volume":"1071","author":"Yehuda","year":"2006","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0129","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/nrdp.2015.57","article-title":"Post-traumatic stress disorder","volume":"1","author":"Yehuda","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-3223(98)00276-5","article-title":"Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event","volume":"44","author":"Yehuda","year":"1998","journal-title":"Biol. Psychiat"},{"key":"10.1016\/j.euroneuro.2022.05.010_bib0131","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/mp.2010.50","article-title":"Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory","volume":"16","author":"Yuen","year":"2011","journal-title":"Mol. Psychiatr"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22002103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22002103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:03:07Z","timestamp":1760378587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22002103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":131,"alternative-id":["S0924977X22002103"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.05.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}